Ingalls & Snyder LLC Amgen Inc Call Options Transaction History

Ingalls & Snyder LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2022 Jan 31, 2023	SELL	$229.03 - $291.01 $2.11 Million - $2.68 Million	-9,200 Reduced 94.85%	500 $131,000
Q4 2021 Feb 11, 2022	BUY	$198.88 - $227.6 $99,440 - $113,800	500 Added 5.43%	9,700 $2.18 Million
Q1 2021 Apr 21, 2021	BUY	$221.91 - $258.6 $1.62 Million - $1.89 Million	7,300 Added 384.21%	9,200 $2.29 Million
Q4 2017 Jan 19, 2018	BUY	$168.79 - $188.59 $320,701 - $358,321	1,900	1,900 $330,000

3,122

410M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Ingalls & Snyder LLC, based on Form 13F filings with the SEC.

Stay updated on Ingalls & Snyder LLC with notifications on news.